market folly

Larry Robbins' hedge fund Glenview Capital filed a 13G with the SEC regarding its position in Lincare Holdings (LNCR). As of October 11th, Glenview owns 6.14% of LNCR with 5,731,403 shares.

This marks an increase of 85% in their position size since the close of the second quarter. Glenview crossed the 5% regulatory threshold in Lincare shares on September 29th and continued buying up to a 6.14% stake.

Glenview was already one of the largest owners of LNCR shares and now they move into the top-5 stakeholders. For other portfolio activity from Robbins' fund, we also detailed Glenview's thesis on Clearwire (CLWR).

Taken from Google Finance, Lincare Holdings is "a provider of oxygen and other respiratory therapy services to patients in the home. Its customers suffer from chronic obstructive pulmonary disease (COPD), such as emphysema, chronic bronchitis or asthma, and require supplemental oxygen or other respiratory therapy services. Lincare also provides a variety of durable medical equipment (DME) and home infusion therapies in certain geographic markets."